Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Project Element Element Description

Project Title

Project Title

Dosage effects of DUF1220 gene subtype CON1 in autism

Principal Investigator

Principal Investigator

Sikela, James

Description

Description

Individuals with autism frequently display accelerated brain growth during infancy and a larger brain size that is also associated with increased symptom severity. Given the widely documented heritability suggesting that autism is predominantly a genetic condition, and the well-established link between autism and abnormally accelerated brain-growth patterns, genes involved in brain growth are excellent candidates for better understanding autism. James Sikela and his team at the University of Colorado, Denver identified one such candidate, the DUF1220 protein domain. Protein domains are conserved segments of a protein that typically carry out important biological functions. Sikela’s team found that DNA sequences that encode DUF1220 domains show the largest human-specific increase in copy number of any gene sequences in the human genome. In addition, the number of DUF1220 copies in the genome closely parallels differences in brain size among primates and humans. However, due to their high copy number (more than 270 copies) in people, DUF1220 domains have not been directly investigated in previous genome-wide studies searching for important autism genes. As part of Sikela’s interest in the genetics of autism, his team has been measuring the number of copies of DUF1220 found in the genomes of individuals with autism. They found in 2014 that that increasing copy number of the DUF1220 subtype CON1 is associated in a linear dose-response manner with increasing severity of each of the three primary symptoms of autism: impaired social reciprocity, impaired communicative ability and increased repetitive behaviors1. Sikela and his team believe that this discovery represents a new direction for studies aimed at understanding the genetic factors contributing to autism severity. They plan to expand on these findings by investigating the association between DUF1220 CON1 copy number and autism severity in a larger, independent autism sample, and by investigating its involvement in multiplex compared with simplex cases of autism. References: 1. Davis J.M. et al. PLoS Genetics 10, e1004241 (2014) PubMed

Funder

Funder

Simons Foundation

Funding Country

Funding Country

United States

Fiscal Year Funding

Fiscal Year Funding

62500

Current Award Period

Current Award Period

2014-2017

Strategic Plan Question

Strategic Plan Question

Question 3: What Causes ASD, and Can Disabling Aspects of ASD be Prevented or Preempted?

Funder’s Project Link

Funder’s Project Link

External Project Page Go to website disclaimer

Institution

Institution

University of Colorado Denver

Institute Location

Institute Location

United States

Project Number

Project Number

309230

Government or Private

Government or Private

Private

History/Related Projects

History/Related Projects

Dosage effects of DUF1220 gene subtype CON1 in autism | 62500 | 2014 | 309230
Dosage effects of DUF1220 gene subtype CON1 in autism | 125000 | 2015 | 309230
Dosage effects of DUF1220 gene subtype CON1 in autism | 0 | 2017 | 309230

Back to Top